Published : Dec-2017
No. of Pages : 38
Table of Contents 3
List of Tables 4
List of Figures 4
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Active Biotech AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Active Biotech AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Active Biotech AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Evotec Extends Co-Development Agreement With Active Biotech 10
Evotec Enters Into An Agreement With Active Biotech 11
Licensing Agreements 12
NeoTX Therapeutics Enters into Licensing Agreement with Active Biotech 12
Equity Offering 13
Active Biotech Raises USD6.1 Million in Rights Offering of Shares 13
Active Biotech to Raise USD30.4 Million in Rights Offering of Shares 14
Active Biotech Completes Private Placement Of Shares For US$42 Million 15
Active Biotech Completes Private Placement Of US$57 Million 16
Active Biotech AB - Key Competitors 17
Active Biotech AB - Key Employees 18
Active Biotech AB - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Nov 09, 2017: Active Biotech AB - Interim report January - September 2017 20
Aug 10, 2017: Active Biotech: Interim report January - June 2017 21
Apr 27, 2017: Active Biotech: Interim Report January - March 2017 23
Feb 16, 2017: Active Biotech Year-end report January - December 2016 26
Aug 11, 2016: Active Biotech Interim report January - June 2016 30
Apr 28, 2016: Active Biotech Interim report January - March 2016 34
Feb 18, 2016: Active Biotech Year-end report January - December 2015 35
Corporate Communications 36
Jun 19, 2017: Helen Tuvesson new CEO of Active Biotech from July 1, 2017 36
Other Significant Developments 37
Dec 07, 2017: Active Biotech provides updated information about the company's financial position - the company currently lacks funding to ensure its operations for the coming twelve-month period 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
Active Biotech AB, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Active Biotech AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Active Biotech AB, Deals By Therapy Area, 2011 to YTD 2017 8
Active Biotech AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Evotec Extends Co-Development Agreement With Active Biotech 10
Evotec Enters Into An Agreement With Active Biotech 11
NeoTX Therapeutics Enters into Licensing Agreement with Active Biotech 12
Active Biotech Raises USD6.1 Million in Rights Offering of Shares 13
Active Biotech to Raise USD30.4 Million in Rights Offering of Shares 14
Active Biotech Completes Private Placement Of Shares For US$42 Million 15
Active Biotech Completes Private Placement Of US$57 Million 16
Active Biotech AB, Key Competitors 17
Active Biotech AB, Key Employees 18
Active Biotech AB, Subsidiaries 19
List of Figures
Active Biotech AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Active Biotech AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
